Ex Vivo and In Vivo Characterization of Interpolymeric Blend/Nanoenabled Gastroretentive Levodopa Delivery Systems

Figure 8

Comparative L-dopa pharmacokinetic curve of Madopar HBS capsules and PXLNET and IPB matrices after single dose administration.